Global Lung Cancer Surgery Market Overview to Reach USD 2.5 Billion by 2034 at a 5.7% of CAGR

The Lung Cancer Surgery Market is projected to be valued at USD 1.4 billion in 2024 and is expected to grow at a CAGR of 5.7% over the forecast period (2024–2034). By 2034, the market value is anticipated to reach USD 2.5 billion.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 𝐭𝐨 𝐠𝐞𝐭 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: https://www.futuremarketinsights.com/report-sample#5245502d47422d333936

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

1. Rising Incidence of Lung Cancer:

   • Lung cancer is the second most common cancer and the leading cause of cancer deaths worldwide.
   • Smoking is the primary risk factor, increasing lung cancer risk by 15 times and accounting for over 80% of lung cancer deaths.
   • The global smoking population is estimated at 1 billion, with numbers expected to surge in the coming decade, particularly in Asia-Pacific and Eastern Europe.

2. Advancements in Surgical Techniques:

   • Minimally invasive techniques, such as Video-Assisted Thoracoscopic Surgery (VATS) and Robot-Assisted Thoracic Surgery (RATS), are gaining traction due to reduced recovery time, less pain, and smaller incisions.
   • Robotic systems offer precision and enhanced visualization, increasing the accuracy of tumor removal.
   • Growing adoption of advanced surgical tools such as harmonic scalpels, endoscopic staplers, and electrocautery devices.

3. Early Detection and Diagnosis:

   • Increased use of low-dose CT (LDCT) scans and biomarker testing enables early detection of lung cancer, leading to improved surgical outcomes.
   • Public health campaigns and awareness initiatives have encouraged early-stage diagnosis, which is more amenable to surgical intervention.

4. Government Initiatives and Supportive Healthcare Policies:

   • Financial assistance programs and insurance coverage are expanding access to lung cancer surgeries.
   • Example: Health Minister’s Cancer Patient Fund (HMCPF) in India provides financial support, attracting domestic and international patients.
   • Government healthcare schemes in China, Thailand, and Brazil are also boosting cancer surgery adoption.

5. Growing Geriatric Population:

   • Aging population is more susceptible to lung cancer due to weakened immunity and long-term exposure to risk factors like smoking and pollution.
   • The increasing elderly population is driving demand for effective and minimally invasive surgical procedures.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

1. Adoption of Robotic-Assisted Surgery:

   • Surgeons are increasingly using robotic-assisted thoracic surgery (RATS) for its precision, 3D visualization, and enhanced dexterity.
   • Major players like Intuitive Surgical’s da Vinci System and Medtronic’s Hugo RAS are dominating the market.

2. Shift Toward Minimally Invasive Techniques:

   • Video-Assisted Thoracoscopic Surgery (VATS) is becoming the standard for lobectomy and wedge resection due to lower morbidity and quicker recovery times.
   • Growing preference for single-port VATS to minimize surgical trauma and postoperative pain.

3. Emergence of Personalized Surgical Approaches:

   • Precision medicine and biomarker testing are influencing surgical planning and treatment strategies.
   • Personalized approaches are improving surgical outcomes and patient survival rates.

4. Integration of Artificial Intelligence (AI) and Augmented Reality (AR):

   • Use of AI-driven imaging and AR-assisted navigation systems for real-time surgical guidance.
   • AI algorithms help in tumor localization, margin assessment, and risk prediction.

5. Increasing Collaborations and Strategic Partnerships:

   • Collaborations between surgical device manufacturers and healthcare providers for R&D and clinical trials.
   • Strategic partnerships to expand product portfolios and market reach.

𝐀 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: https://www.futuremarketinsights.com/reports/lung-cancer-surgery-market

𝐓𝐲𝐩𝐞𝐬 𝐨𝐟 𝐋𝐮𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐒𝐮𝐫𝐠𝐞𝐫𝐢𝐞𝐬:

1. Lobectomy:

   • Most common surgical procedure for early-stage non-small cell lung cancer (NSCLC).
   • Involves removal of an entire lobe of the lung.
   • VATS lobectomy and robotic-assisted lobectomy are gaining popularity.

2. Segmentectomy/Wedge Resection:

   • Involves removal of a small, localized portion of the lung.
   • Preferred for small peripheral tumors and patients with limited pulmonary function.
   • Increasing use of minimally invasive techniques like VATS.

3. Pneumonectomy:

   • Complete removal of one lung, typically for centrally located tumors.
   • Performed less frequently due to high morbidity and mortality rates.

4. Sleeve Lobectomy:

   • Involves removal of a lobe and a portion of the bronchus, followed by rejoining the remaining lung tissue.
   • Preserves lung function compared to pneumonectomy.

5. Radiofrequency Ablation (RFA) and Cryosurgery:

   • Minimally invasive alternatives for inoperable lung cancer or small peripheral tumors.
   • Involves targeted destruction of tumor cells using heat (RFA) or extreme cold (Cryosurgery).

𝐄𝐧𝐝-𝐔𝐬𝐞𝐫:

1. Hospitals and Surgical Centers:

   • Largest end-user segment due to availability of advanced surgical equipment and expert thoracic surgeons.
   • Adoption of robotic-assisted systems and minimally invasive techniques.

2. Specialty Cancer Clinics:

   • Focus on comprehensive cancer care, including diagnosis, surgery, and post-operative care.
   • Increasing use of multidisciplinary approaches for personalized cancer treatment.

3. Ambulatory Surgical Centers (ASCs):

   • Growing preference for outpatient surgeries due to reduced hospital stay and cost-effectiveness.
   • Surge in minimally invasive procedures performed in ASCs.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

• The Lung Cancer Surgery Market is projected to reach USD 2.5 billion by 2034, growing at a CAGR of 5.7%.
• Technological advancements, early diagnosis, and government healthcare initiatives are driving market growth.
• North America dominates the market, while Asia-Pacific is the fastest-growing region.

𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐃𝐞𝐯𝐢𝐜𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬, 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬, 𝐚𝐧𝐝 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝟏𝟓+ 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬: https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Key players are focusing on innovation, strategic collaborations, and geographical expansion. Leading companies include:

• Asap Endoscopic Products
• Ethicon Inc. (J & J)
• Medtronic Plc.
• Germed USA Inc.
• Teleflex Incorporated
• B. Braun Melsungen AG
• Karl Storz
• Richard Wolf
• Olympus Medical Systems Corp
• Intuitive Surgical Inc.
• Ambu A/S
• PENTAX Medical Company
• FUJIFILM Holdings Corporation

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭

By Product:

By product, the market includes thoracoscopes, mediastinoscopes, bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers, surgical energy instruments, advanced energy instruments, advanced bipolar instruments, ultrasonic instruments, basic energy instruments, bipolar instruments, and monopolar instruments.

By Application:

By application, the primary procedures are lobectomy, segmentectomy, wedge resection, and pneumonectomy.

By End-user:

By end-user, the market is divided into hospitals and ambulatory surgical centres.

By Region:

The industry is spread across North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.